Anti‐VEGF‐A/ANG2 combotherapy limits pathological angiogenesis in the eye: a replication study
Abstract Neovascular and inflammatory retinal diseases including wet age‐related macular degeneration (AMD) can cause severe vision loss among the elderly. Simultaneous neutralization of vascular endothelial growth factor‐A (VEGF‐A) and angiopoietin 2 (ANG2) is envisioned as a novel candidate approa...
Saved in:
| Main Authors: | Anne Wolf, Thomas Langmann |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2019-04-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.201910362 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Berberine chloride inhibits proliferation and angiogenesis in triple-negative breast cancer by down-regulating HIF-1α/VEGF/Ang pathway
by: Nishmaa Sulthan Mohideen, et al.
Published: (2025-05-01) -
Targeting retinal angiogenesis: sex differences in adverse reactions to anti-VEGF therapies
by: Eleonora Castellana, et al.
Published: (2025-07-01) -
Efficacy of simultaneous VEGF‐A/ANG‐2 neutralization in suppressing spontaneous choroidal neovascularization
by: Richard H Foxton, et al.
Published: (2019-04-01) -
Fisetin Prevents Angiogenesis in Diabetic Retinopathy by Downregulating VEGF
by: Meihua Lai, et al.
Published: (2023-01-01) -
Role of S1PR1 in VEGF-exosomes mediated resistance of hepatocellular carcinoma to anti-angiogenesis therapy
by: Xinghong Yao, et al.
Published: (2025-07-01)